Skip to content

MHealth for Antiretroviral adherence

The acceptability and effectiveness of a mobile-health intervention to improve adherence to treatment and medication for people living with HIV

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100601004076N23
Enrollment
50
Registered
2019-03-09
Start date
2019-04-04
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. Human immunodeficiency virus [HIV] disease

Interventions

Intervention 1: Intervention group: Mobile messages will be sent to the intervention group to provide personalized support through counseling and reminders to improve adherence to medication. Adherenc

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All PLHIV will be eligible to participate if they are receiving ART aged 18 years or above own or have sufficient access to a mobile phone are able to sufficiently operate a cell phone to communicate using mobile-messaging (help by a partner is sufficient for patients with reading and/or writing difficulties)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Adherence to HIV treatment. Timepoint: Every week. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Vira Load. Timepoint: At the end of intervention. Method of measurement: Lab Test.;CD4 Cell Count. Timepoint: At the end of the intervention. Method of measurement: Lab test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMinoo Mohraz

Tehran University of Medical Sciences

ircha@tums.ac.ir+98 21 6694 7984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026